HomeTCRX • NASDAQ
Tscan Therapeutics Inc
add
$1.72
7.50%
After Hours:(0.48%)+0.0083
$1.73
Closed: Sep 18, 6:17:15 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.08M | 473.88% |
Operating expense | 9.10M | 17.01% |
Net income | -36.95M | -16.71% |
Net profit margin | -1.20K | 79.66% |
Earnings per share | -0.28 | 0.00% |
EBITDA | -37.96M | -15.02% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 218.05M | -26.75% |
Total assets | 298.56M | -20.36% |
Total liabilities | 121.85M | 1.84% |
Total equity | 176.71M | — |
Shares outstanding | 56.75M | — |
Price to book | 0.51 | — |
Return on assets | -30.62% | — |
Return on capital | -33.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -36.95M | -16.71% |
Cash from operations | -33.27M | -26.85% |
Cash from investing | 48.44M | 243.66% |
Cash from financing | 116.00K | -99.93% |
Net change in cash | 15.29M | -84.96% |
Free cash flow | -19.91M | -33.54% |
Previous close
$1.60
Day range
$1.61 - $1.73
Year range
$1.03 - $6.23
Market cap
97.00M USD
Avg Volume
220.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
208
